ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,743, issued on Aug. 18, was assigned to CHINA AGRICULTURAL UNIVERSITY (Beijing).
"Compositions and methods for CRISPR/Cas-based gene editing" was invented by Jinsheng Lai (Beijing), Zhijia Yang (Beijing), Meixia Yu (Beijing), Jian Chen (Beijing), Beibei Xin (Beijing), Yunpeng Teng (Beijing), Yueheng Zhou (Beijing), Haiming Zhao (Beijing) and Weibin Song (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of nucleic acid editing, in particular to the field of clustered regularly interspaced short palindromic repeat (CRISPR) technology. Specifically, the present invention relates to Cas effector proteins,...